- Exploring the Perception on Drug Utilization Review System and DUR Modernization Pilot Project: A Qualitative Study Using Focus Group Interviews
-
Bea S, Jeon HL, Yoon D, Choi A, Lee H, Shin JY
- KMID: 2517308
- Korean J Clin Pharm.
- 2021 Jun;31(2):104-114.
- doi: 10.24304/kjcp.2021.31.2.104
Objective: To explore the perception of drug utilization review (DUR) system and DUR modernization pilot project among healthcare professionals and patients. Methods: We conducted 8 times of focus group interviews... -
- CITED
-
- Close
- SHARE
-
- Close
- Investigation on Perceptions, Attitudes, and Contributing Factors to Spontaneous Adverse Drug Reaction Reporting among Community Pharmacists: Results from a Web-based Survey
-
Lee MS, Choi AH, Jang BH, Kim NY, Lee JM, Shin JY, Jeon HL
- KMID: 2452861
- Korean J Clin Pharm.
- 2019 Jun;29(2):125-132.
- doi: 10.24304/kjcp.2019.29.2.125
OBJECTIVE: To examine the perceptions and attitudes toward spontaneous adverse drug reaction (ADR) reporting system among community pharmacists and identify factors that influence reporting, by implementing a survey. METHODS: A structured... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Statins, Metformin, Angiotensin-Converting Enzyme Inhibitors, and Angiotensin II Receptor Blockers on Age-Related Macular Degeneration
-
Lee H, Jeon HL, Park SJ, Shin JY
- KMID: 2450408
- Yonsei Med J.
- 2019 Jul;60(7):679-686.
- doi: 10.3349/ymj.2019.60.7.679
PURPOSE: Statins, metformin, angiotensin-converting enzyme (ACE) inhibitors, and angiotensin receptor blockers (ARBs) have been suggested for treating age-related macular degeneration (AMD) due to their pleiotropic effects. Therefore, we investigated whether... -
- CITED
-
- Close
- SHARE
-
- Close
- A Nationwide Survey of mRNA COVID-19 Vaccinee’s Experiences on Adverse Events and Its Associated Factors
-
Yoon D, Jeon HL, Noh Y, Choe YJ, Choe SA, Jung J, Shin JY
- KMID: 2542802
- J Korean Med Sci.
- 2023 Jun;38(22):e170.
- doi: 10.3346/jkms.2023.38.e170
Background: Although coronavirus disease 2019 (COVID-19) vaccines have been distributed worldwide under emergency use authorization, the real-world safety profiles of mRNA vaccines still need to be clearly defined. We aimed... -
- CITED
-
- Close
- SHARE
-
- Close
